Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.

Cytometry. Part B, Clinical cytometry - 1 Mar 2006

Monreal Mariela B, Pardo Maria L, Pavlovsky Miguel A, Fernandez Isolda, Corrado Claudia S, Giere Isabel, Sapia Sandra, Pavlovsky Santiago

Abstract excerpt

BACKGROUND: Myelodysplastic syndromes (MDS) are clonal disorders affecting hematopoietic progenitor cells (HPC). Despite the relevance of clonal CD34+ cells in developing MDS, only few studies analyze the phenotype of this cell population. The aim of this study was to evaluate phenotypic changes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-ribosyl Cyclase 1
Share to Antigens, CD34
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Non-Hodgkin

Share to Multiple Myeloma

Share to Myelodysplastic Syndromes

Share to Observer Variation

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Source

Identifiers

PMID: 16470534
DOI: 10.1002/cyto.b.20088

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-16470534-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.PMID 16470534Read ↗

Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progressionSemantic proximity Read ↗

Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeSemantic proximity Read ↗

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterationsSemantic proximity Read ↗

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursorsSemantic proximity Read ↗

Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms.Semantic proximity Read ↗

Detection of molecular targets on the surface of CD34<sup>+</sup>CD38<sup>−</sup> bone marrow cells in myelodysplastic syndromesSemantic proximity Read ↗

Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.Semantic proximity Read ↗

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.Semantic proximity Read ↗

Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia.Semantic proximity Read ↗

Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromesSemantic proximity Read ↗

Elevated mature monocytes in bone marrow accompanied with a higher IPSS-R score predicts a poor prognosis in myelodysplastic syndromes.Semantic proximity Read ↗

Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.